Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02118818Completed

RhEumatiC Heart diseAse Genetics

Role: collaborator

NCT04283929Not ApplicableUnknown

Evaluation of Clinical Impacts and Costs of eHealth in Rwanda

Role: lead

NCT02514122Phase 2Completed

Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda

Role: collaborator

NCT01836731Not ApplicableCompleted

Impact Evaluation of Community-Based Health Programs in Rwanda

Role: collaborator

NCT02239250Not ApplicableCompleted

Water Filters and Improved Cookstoves in Western Rwanda

Role: collaborator

NCT01424046Not ApplicableCompleted

Health Care for Type 1 Diabetes in Developing World

Role: collaborator

All 6 trials loaded